US Stock Insider Trading | InspireMD Discloses 10 Insider Transactions on February 2

K-LinePoet · 2026-02-04T09:58:50+00:00

On February 2, 2026, InspireMD executive Gleason Shane Thomas disclosed multiple insider transactions, including selling 17,600 shares on January 21, with a total transaction amount of $28,600. The company focuses on developing medical devices and MicroNe stent platform technology.

K-LinePoet

2026-02-04 09:58:50

Abstract generation in progress

On February 2, 2026, InspireMD (NSPR) disclosed 10 insider trading transactions. Executive Gleason Shane Thomas sold 17,600 shares on February 2, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 2, 2026	Executive	Gleason Shane Thomas	January 21, 2026	Sell	17,600	1.62	28,600
February 2, 2026	Executive	Gleason Shane Thomas	January 29, 2026	Sell	5,000	1.65	8,250.00
February 2, 2026	Executive	Gleason Shane Thomas	February 2, 2026	Sell	2,000	1.60	3,208.00
February 2, 2026	Executive	Gleason Shane Thomas	January 22, 2026	Sell	8,411	1.57	13,200
February 2, 2026	Executive	Gleason Shane Thomas	January 16, 2026	Sell	2,250	1.61	3,627.00
February 2, 2026	Executive	Gleason Shane Thomas	January 30, 2026	Sell	2,900	1.63	4,729.90
February 2, 2026	Executive	Gleason Shane Thomas	January 20, 2026	Sell	2,955	1.59	4,710.27
February 2, 2026	Executive	Gleason Shane Thomas	January 15, 2026	Sell	2,909	1.58	4,593.31
February 2, 2026	Executive	Gleason Shane Thomas	January 27, 2026	Sell	4,781	1.66	7,955.58
February 2, 2026	Executive	Gleason Shane Thomas	January 28, 2026	Sell	12,000	1.65	20,500

【Company Profile】

InspireMD, Inc. was incorporated on February 29, 2008, in Delaware. The company was originally called Saguaro Resources, Inc., involved in the acquisition, exploration, and development of natural resources. On March 28, 2011, the company renamed itself to InspireMD, Inc. It is a medical device company focused on developing and commercializing its proprietary MicroNet stent platform technology for treating complex vascular and coronary artery diseases. A stent is a expandable, “stent-like” device, typically made of metal, inserted into arteries to expand the internal passage and improve blood flow. MicroNet is a micron-sized mesh sleeve wrapped around the stent, providing embolic protection during stent implantation.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.